New research suggests the protection the Moderna vaccine gives against COVID-19 lasts for at least six months.
The report Tuesday in the New England Journal of Medicine echoes what Pfizer said last week about its vaccine, which works in a similar way.
Both reports were based on follow-up tests in dozens of people who received the shots during studies that led to the vaccines’ use. Those studies were done before troubling new variants of the coronavirus had emerged and started to spread.
Illustrative: A Palestinian medic displays a vial of the Moderna COVID-19 vaccine in the West Bank city of Bethlehem, February 3, 2021, as the Palestinian Authority began administering coronavirus vaccinations after receiving several thousands of doses of the Moderna vaccine from Israel. (AP Photo/Nasser Nasser)
A separate report in the medical journal adds to concerns about the variants. Scientists measured antibodies that can block the virus in 50 people who had been given the Sinopharm or Sinovac vaccines that were developed in China. Many showed total or partial loss of effectiveness against a virus variant first detected in South Africa.
The vaccines still seemed to protect against a variant first found in the United Kingdom that is now rapidly spreading in the United States and elsewhere.
Pfizer and Moderna have said they are working to update their vaccines, or possibly design a booster shot, in case they’re needed against variants.
Is our live election coverage important to you?
Are you relying on The Times of Israel for accurate and timely coverage of the 2026 Israeli election? If so, please join The Times of Israel Community. For as little as $6/month, you will:
Support our independent journalists who are working around the clock to report political developments as they unfold;
Read ToI with a clear, ads-free experience on our site, apps and podcasts; and
Gain access to exclusive content shared only with the ToI Community, including our DocuNationseries and weekly letters from founding editor David Horovitz.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel